Commentary by Jon-Emile Kenny MD, PGY- 2
Please also see the clinical vignette presented before last week’s grand rounds.
Medical grand rounds on November 12, 2008 was given by Dr. Jose Baselga, MD. His lecture, …
Commentary by Jon-Emile Kenny MD, PGY- 2
Please also see the clinical vignette presented before last week’s grand rounds.
Medical grand rounds on November 12, 2008 was given by Dr. Jose Baselga, MD. His lecture, …
Commentary by Yelena Kopyltsova MD, PGY-2
Please also see the clinical vignette presented before last week’s grand rounds.
Last week’s grand rounds speaker was Simon Karpatkin MD, NYU Professor of Medicine & Director of the NYU Division of Hematology. In the 80s, multiple cases of autoimmune …
Commentary by Sabina Berezovskaya MD PGY-3
Please also see the clinical vignette presented during last week’s grand rounds
On Wednesday, October 8, 2004, the NYU Department of Medicine Grand Rounds featured guest lecturer Vincent Yang, M.D. Ph.D., Professor of Medicine and …
Commentary by Andrew McKinstry MD, PGY-1 (reviewed by Michael Poles, MD, Associate Editor Clinical Correlations, Assistant Professor of Medicine, Section of Gastroenterology)
Hot on the heels of its recommendation in August against routine screening for prostate cancer in men over 75, the US Preventive Services Task Force has issued recommendations against routine …
Commentary by Daniel Egan MD, PGY2
Please also see the clinical vignette presented during last week’sgrand rounds
On Wednesday, September 24, 2008, the NYU Department of Medicine Grand Rounds featured guest speaker Hilary Calvert, …
Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.
Commentary by Daniel Green …
Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations
The US Preventive Services Task Force issued new guidelines for prostate cancer screening on Monday. For the first time, the task force recommends AGAINST routine screening in patients over 75 years of age, citing the “moderate to substantial” harms over small to no benefits from screening. …
Commentary by Rachana Jani MD, PGY-1 and Neal Steigbigel MD, Professor of Medicine (Infectious Diseases/Immunology)
Rachana Jani MD: Walking onto an oncology floor, one cannot help but notice the precautionary signs that segregate …